Active case detection, treatment of falciparum malaria with combined chloroquine and sulphadoxine/pyrimethamine and vivax malaria with chloroquine and molecular markers of anti-malarial resistance in the Republic of Vanuatu

Malaria Journal

Volumn 9, Issue 1, 2010, Pages

  Kinzer, Michael H ^a   Chand, Krisin ^a   Basri, Hasan ^a   Lederman, Edith R ^a   Susanti, Augustina I ^a   Elyazar, Iqbal ^a   Taleo, George ^b   Rogers, William O ^a   Bangs, Michael J ^c   Maguire, Jason D ^a  

^a US Naval Medical Research Unit No 2 Jakarta   (Indonesia)

^b Ministry of Health   (Vanuatu)

^c Public Health and Malaria Control Department Papua   (Indonesia)

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROQUINE; MEROZOITE SURFACE PROTEIN 2; MOLECULAR MARKER; PYRIMETHAMINE; SULFADOXINE; ANTIMALARIAL AGENT; CARRIER PROTEIN; FANSIDAR; MEROZOITE SURFACE PROTEIN 2, PLASMODIUM; PARASITE ANTIGEN; PFCRT PROTEIN, PLASMODIUM FALCIPARUM; PROTOZOAL PROTEIN; SULFADOXINE-PYRIMETHAMINE;

ADULT; ALLELE; ANTIMALARIAL DRUG RESISTANCE; ARTICLE; BLOOD SMEAR; CHILD; CLINICAL ASSESSMENT; COHORT ANALYSIS; DIAGNOSTIC ACCURACY; DRUG EFFICACY; ENDEMIC DISEASE; FEBRILE BONE MARROW APLASIA; FEMALE; FOLLOW UP; GENOTYPE; HUMAN; INFECTION PREVENTION; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MALE; MASS SCREENING; MUTANT; PARASITE IDENTIFICATION; PARASITE ISOLATION; PARASITEMIA; PLASMODIUM VIVAX MALARIA; PREVALENCE; SEASONAL VARIATION; SENSITIVITY AND SPECIFICITY; TREATMENT FAILURE; VANUATU; ADOLESCENT; CASE CONTROL STUDY; CROSS-SECTIONAL STUDY; DRUG COMBINATION; DRUG EFFECT; DRUG RESISTANCE; GENETIC MARKER; GENETICS; INCIDENCE; ISOLATION AND PURIFICATION; MIDDLE AGED; PARASITOLOGY; PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; PRESCHOOL CHILD; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ANTIGENS, PROTOZOAN; ANTIMALARIALS; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; CHLOROQUINE; CROSS-SECTIONAL STUDIES; DRUG COMBINATIONS; DRUG RESISTANCE; DRUG THERAPY, COMBINATION; FEMALE; GENETIC MARKERS; HUMANS; INCIDENCE; MALARIA, FALCIPARUM; MALARIA, VIVAX; MALE; MEMBRANE TRANSPORT PROTEINS; MIDDLE AGED; PARASITEMIA; PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; PROTOZOAN PROTEINS; PYRIMETHAMINE; SULFADOXINE; TREATMENT OUTCOME; VANUATU; YOUNG ADULT;

EID: 77950542073     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-9-89     Document Type: Article

References (42)

1. Chloroquine-resistant Plasmodium falciparum malaria in Vanuatu. DK Bowden P Bastien FP Douglas JW Muir E Tambisari, Med J Aust 1982 2 561 562 6761561
2. [The chloroquine resistance of Plasmodium falciparum in Vanuatu (1980-1984): appearance, evolution, distribution](in French). P Bastien P Saliou M Gentilini, Bull Soc Pathol Exot Filiales 1988 81 226 237 3046769
3. Vanuatu Ministry of Health, Vanuatu Malaria Control Programme Data Book: 1983-1997 Port Vila: Ministry of Health 1998
4. Cross-sectional characterization of malaria in Sanma and Shefa Provinces, Republic of Vanuatu: malaria control implications. JD Maguire MJ Bangs L Brennan K Rieckmann G Taleo, P N G Med J 2006 49 22 31 18396609
5. Chloroquine or amodiaquine combined with sulfadoxine-pyrimethamine as a treatment for uncomplicated malaria - a systematic review. HM McIntosh BM Greenwood, Ann Trop Med Parasitol 1998 92 265 270 10.1080/00034989859825 9713541
6. A randomized, parallel-group study in Mumbai (Bombay), comparing chloroquine with chloroquine plus sulfadoxine-pyrimethamine in the treatment of adults with acute, uncomplicated, Plasmodium falciparum malaria. NJ Gogtay S Desai VS Kadam KD Kamtekar SS Dalvi NA Kshirsagar, Ann Trop Med Parasitol 2000 94 309 312 10.1080/00034980050034545 10945039
7. Atovaquone-proguanil compared with chloroquine and chloroquine- sulfadoxine-pyrimethamine for treatment of acute Plasmodium falciparum malaria in the Philippines. DG Bustos CJ Canfield E Canete-Miguel DB Hutchinson, J Infect Dis 1999 179 1587 1590 10.1086/314770 10228090
8. Chloroquine or sulfadoxine-pyrimethamine for the treatment of uncomplicated, Plasmodium falciparum malaria during an epidemic in Central Java, Indonesia. JD Maguire MD Lacy Sururi P Sismadi Krisin I Wiady B Laksana MJ Bangs S Masbar I Susanti W Basuki MJ Barcus H Marwoto MD Edstein S Tjokrosonto JK Baird, Ann Trop Med Parasitol 2002 96 655 668 10.1179/000349802125002310 12537627
9. Malaria eradication on islands. A Kaneko G Taleo M Kalkoa S Yamar T Kobayakawa A Bjorkman, Lancet 2000 356 1560 1564 10.1016/S0140-6736(00)03127-5 11075770
10. Therapeutic efficacy of chloroquine plus sulphadoxine/pyrimethamine compared with monotherapy with either chloroquine or sulphadoxine/pyrimethamine in uncomplicated Plasmodium falciparum malaria in Laos. B Schwobel S Jordan V Vanisaveth R Phetsouvanh EM Christophel S Phompida F Von Sonnenburg T Jelinek, Trop Med Int Health 2003 8 19 24 10.1046/j.1365-3156.2003.00977.x 12535245
11. The efficacy of chloroquine, sulfadoxine-pyrimethamine and a combination of both for the treatment of uncomplicated Plasmodium falciparum malaria in an area of low transmission in western Uganda. R Ndyomugyenyi P Magnussen S Clarke, Trop Med Int Health 2004 9 47 52 10.1046/j.1365-3156.2003.01167.x 14728606
12. Resistance to antimalarials by Plasmodium falciparum in Arso PIR, Irian Jaya, Indonesia. JK Baird H Basri TR Jones Purnomo MJ Bangs A Ritonga, Am J Trop Med Hyg 1991 44 640 4 1858967
13. Vivax malaria resistant to treatment and prophylaxis with chloroquine. GS Murphy H Basri Purnomo EM Andersen MJ Bangs DL Mount J Gorden AA Lal AR Purwokusumo S Harjosuwarno K Sorensen SL Hoffman, Lancet 1993 341 96 100 10.1016/0140-6736(93)92568-E 8093414
14. Chloroquine/doxycycline combination versus chloroquine alone, and doxycycline alone for the treatment of Plasmodium falciparum and Plasmodium vivax malaria in northeastern Irian Jaya, Indonesia. WR Taylor H Widjaja TL Richie H Basri C Ohrt Tjitra E Taufik TR Jones KC Kain SL Hoffman, Am J Trop Med Hyg 2001 64 223 8 11463107
15. Mefloquine is highly efficacious against chloroquine-resistant Plasmodium vivax malaria and P. falciparum malaria in Papua, Indonesia. JD Maguire Krisin H Marwoto TL Richie DJ Fryauff JK Baird, Clin Inf Dis 2006 42 1067 72 10.1086/501357
16. A molecular marker for chloroquine-resistant falciparum malaria. A Djimde OK Doumbo JF Cortese K Kayentao S Doumbo Y Diourte A Dicko XZ Su T Nomura DA Fidock TE Wellems CV Plowe D Coulibaly, NEJM 2001 344 257 263 10.1056/NEJM200101253440403 11172152
17. [Plasmodium chaubadi : enzymatic synthesis of dihydropteroate and its inhibition by sulfonamides](in German). RD Walter E Konigk, Z Tropenmed Parasitol 1971 22 256 259 5134866
18. Plasmodium berghei dihydrofolate reductase. Isolation, properties, and inhibition by antifolates. R Ferone JJ Burchall GH Hitchings, Mol Pharmacol 1969 5 49 59 4392112
19. Amino acid changes linked to pyrimethamine resistance in the dihydrofolate reductase-thymidylate synthase gene of Plasmodium falciparum. AF Cowman MJ Morry BA Biggs GA Cross SJ Foote, Proc Natl Acad Sci USA 1988 85 9109 9113 10.1073/pnas.85.23.9109 3057499
20. Evidence that a point mutation in dihydrofolate reductase-thymidylate synthase confers resistance to pyrimethamine in falciparum malaria. DS Peterson D Walliker TE Wellems, Proc Natl Acad Sci USA 1988 85 9114 9118 10.1073/pnas.85.23.9114 2904149
21. Allelic exchange at the endogenous genomic locus in Plasmodium falciparum proves the role of dihydropteroate synthase in sulfadoxine-resistant malaria. T Triglia P Wang PF Sims JE Hyde AF Cowman, EMBO J 1998 17 3807 3815 10.1093/emboj/17.14.3807 9669998
22. Amino acid mutations in Plasmodium vivax DHFR and DHPS from several geographical regions and susceptibility to antifolate drugs. A Auliff DW Wilson B Russell Q Gao N Chen N Anh le J Maguire D Bell MT O'Neil Q Cheng, Am J Trop Med Hyg 2006 75 617 621 17038682
23. Preventing antimalarial drug resistance through combinations. NJ White, Drug Resist Updat 1998 1 3 9 10.1016/S1368-7646(98)80208-2 17092790
24. Salinity tolerance of Anopheles farauti Laveran sensu stricto. D Bell J Bryan A Cameron D Foley K Pholsyna, P N G Med J 1999 42 5 9 11061001
25. The Anopheles punctulatus group of mosquitoes in the Solomon Islands and Vanuatu surveyed by allozyme electrophoresis. DH Foley SR Meek JH Bryan, Med Vet Entomol 1994 8 340 350 10.1111/j.1365-2915.1994.tb00098.x 7841489
26. World Health Organization, Assessment of therapeutic efficacy of antimalarial drugs for uncomplicated falciparum malaria. Version 3, Draft March 3, 2001 Geneva, Division of Tropical Diseases Control, WHO 2001
27. In vivo resistance to chloroquine by Plasmodium vivax and Plasmodium falciparum at Nabire, Irian Jaya, Indonesia. JK Baird I Wiady DJ Fryauff MA Sutanihardja B Leksana H Widjaya Kysdarmanto B Subianto, Am J Trop Med Hyg 1997 56 627 31 9230793
28. Sequence analysis of the apical membrane antigen I (AMA-1) of Plasmodium vivax. Q Cheng A Saul, Mol Biochem Parasitol 1994 65 183 187 10.1016/0166-6851(94)90127-9 7935625
29. Plasmodium falciparum : a rapid technique for genotyping the merozoite surface protein 2. I Felger L Tavul HP Beck, Exp Parasitol 1993 77 372 375 10.1006/expr.1993.1094 7901048
30. Therapeutic efficacies of artesunate-sulfadoxine-pyrimethamine and chloroquine-sulfadoxine-pyrimethamine in vivax malaria pilot studies: relationship to Plasmodium vivax dhfr mutations. E Tjitra J Baker S Suprianto Q Cheng NM Anstey, Antimicrob Agents Chemother 2002 46 3947 3953 10.1128/AAC.46.12.3947-3953.2002 12435700
31. Sulfadoxine resistance in Plasmodium vivax is associated with a specific amino acid in dihydropteroate synthase at the putative sulfadoxine-binding site. M Korsinczky K Fischer N Chen J Baker K Rieckmann Q Cheng, Antimicrob Agents Chemother 2004 48 2214 2222 10.1128/AAC.48.6.2214-2222.2004 15155224
32. Clinical case definitions and malaria vaccine efficacy. WO Rogers F Atuguba AR Oduro A Hodgson KA Koram, J Infect Dis 2006 193 467 473 10.1086/499314 16388497
33. In vivo resistance to chloroquine by Plasmodium vivax and Plasmodium falciparum at Nabire, Irian Jaya, Indonesia. JK Baird I Wiady DJ Fryauff MA Sutanihardja B Leksana H Widjaya Kysdarmanto B Subianto, Am J Trop Med Hyg 1997 56 627 631 9230793 (Pubitemid 27318584)
34. A trial of Fansidar plus chloroquine or Fansidar alone for the treatment of uncomplicated malaria in Gambian children. KA Bojang G Schneider S Forck SK Obaro S Jaffar M Pinder J Rowley BM Greenwood, Trans R Soc Trop Med Hyg 1998 92 73 76 10.1016/S0035-9203(98)90962-2 9692160
35. Efficacy of sulphadoxine-pyrimethamine alone or combined with amodiaquine or chloroquine for the treatment of uncomplicated falciparum malaria in Ugandan children. AO Talisuna A Nalunkuma-Kazibwe N Bakyaita P Langi TK Mutabingwa WW Watkins E Van Marck U D'Alessandro TG Egwang, Trop Med Int Health 2004 9 222 229 10.1046/j.1365-3156.2003.01187.x 15040559 (Pubitemid 38250809)
36. Comparative efficacy of chloroquine plus chlorpheniramine alone and in a sequential combination with sulfadoxine-pyrimethamine, for the treatment of acute, uncomplicated, falciparum malaria in children. A Sowunmi FA Fehintola AA Adedeji AG Falade CO Falade OO Akinyinka AM Oduola, Ann Trop Med Parasitol 2000 94 209 217 10.1080/00034980050006375 10884864
37. Comparative efficacy of chloroquine and sulfadoxine-pyrimethamine for uncomplicated Plasmodium falciparum malaria and impact on gametocyte carriage rates in the East Nusatenggara province of Indonesia. I Sutanto S Supriyanto P Ruckert Purnomo JD Maguire MJ Bangs, Am J Trop Med Hyg 2004 70 467 473 15155977
38. Enhanced gametocyte production in Fansidar-treated Plasmodium falciparum malaria patients: implications for malaria transmission control programmes. C Puta C Manyando, Trop Med Int Health 1997 2 227 229 10.1046/j.1365-3156.1997. d01-267.x 9491100
39. Limited recombination events in merozoite surface protein-1 alleles of Plasmodium falciparum on islands. N Sakihama A Kaneko T Hattori K Tanabe, Gene 2001 279 41 48 10.1016/S0378-1119(01)00748-X 11722844
40. Pyrimethamine-sulfadoxine resistance in Plasmodium falciparum : what next? CH Sibley JE Hyde PF Sims CV Plowe JG Kublin EK Mberu AF Cowman PA Winstanley WM Watkins AM Nzila, Trends Parasitol 2001 17 582 588 10.1016/S1471-4922(01)02085-2 11756042
41. An evaluation of five regimens for the outpatient therapy of falciparum malaria in Thailand 1980-81. S Pinichpongse EB Doberstyn JR Cullen L Yisunsri Y Thongsombun K Thimasarn, Bull World Health Organ 1982 60 907 912 6761005
42. Malaria epidemiology, glucose 6-phosphate dehydrogenase deficiency and human settlement in the Vanuatu Archipelago. A Kaneko G Taleo M Kalkoa J Yaviong PA Reeve M Ganczakowski C Shirakawa K Palmer T Kobayakawa A Björkman, Acta Trop 1998 70 285 302 10.1016/S0001-706X(98)00035-7 9777715 (Pubitemid 28386712)